• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

实验和计算方法在化学生物学和药物发现中提高结合亲和力。

Experimental and Computational Approaches to Improve Binding Affinity in Chemical Biology and Drug Discovery.

机构信息

In silico Research Laboratory, Eminent Biosciences, Mahalakshmi Nagar, Indore - 452010, Madhya Pradesh, India.

出版信息

Curr Top Med Chem. 2020;20(19):1651-1660. doi: 10.2174/156802662019200701164759.

DOI:10.2174/156802662019200701164759
PMID:32614747
Abstract

Drug discovery is one of the most complicated processes and establishment of a single drug may require multidisciplinary attempts to design efficient and commercially viable drugs. The main purpose of drug design is to identify a chemical compound or inhibitor that can bind to an active site of a specific cavity on a target protein. The traditional drug design methods involved various experimental based approaches including random screening of chemicals found in nature or can be synthesized directly in chemical laboratories. Except for the long cycle design and time, high cost is also the major issue of concern. Modernized computer-based algorithm including structure-based drug design has accelerated the drug design and discovery process adequately. Surprisingly from the past decade remarkable progress has been made concerned with all area of drug design and discovery. CADD (Computer Aided Drug Designing) based tools shorten the conventional cycle size and also generate chemically more stable and worthy compounds and hence reduce the drug discovery cost. This special edition of editorial comprises the combination of seven research and review articles set emphasis especially on the computational approaches along with the experimental approaches using a chemical synthesizing for the binding affinity in chemical biology and discovery as a salient used in de-novo drug designing. This set of articles exfoliates the role that systems biology and the evaluation of ligand affinity in drug design and discovery for the future.

摘要

药物发现是最复杂的过程之一,建立一种单一的药物可能需要多学科的努力来设计高效和商业可行的药物。药物设计的主要目的是确定一种化学化合物或抑制剂,它可以与靶蛋白上特定腔的活性部位结合。传统的药物设计方法涉及各种基于实验的方法,包括随机筛选自然界中发现的化学物质,或直接在化学实验室中合成。除了设计和时间周期长,高成本也是一个主要的关注点。基于计算机的现代化算法,包括基于结构的药物设计,已经充分加速了药物设计和发现的过程。令人惊讶的是,在过去的十年中,药物设计和发现的所有领域都取得了显著的进展。基于计算机辅助药物设计(CADD)的工具缩短了传统的周期大小,并且产生了化学上更稳定和有价值的化合物,从而降低了药物发现的成本。本期特刊由七篇研究和综述文章组成,特别强调了计算方法和化学合成方法的结合,用于化学生物学中的结合亲和力和发现,作为从头设计药物的一个突出用途。这组文章阐明了系统生物学和配体亲和力在药物设计和发现中的作用,为未来的发展提供了参考。

相似文献

1
Experimental and Computational Approaches to Improve Binding Affinity in Chemical Biology and Drug Discovery.实验和计算方法在化学生物学和药物发现中提高结合亲和力。
Curr Top Med Chem. 2020;20(19):1651-1660. doi: 10.2174/156802662019200701164759.
2
Combating Diseases with Computational Strategies Used for Drug Design and Discovery.运用药物设计与发现的计算策略来对抗疾病。
Curr Top Med Chem. 2018;18(32):2743-2773. doi: 10.2174/1568026619666190121125106.
3
Role of computer-aided drug design in modern drug discovery.计算机辅助药物设计在现代药物发现中的作用。
Arch Pharm Res. 2015 Sep;38(9):1686-701. doi: 10.1007/s12272-015-0640-5. Epub 2015 Jul 25.
4
Insights into Machine Learning-based Approaches for Virtual Screening in Drug Discovery: Existing Strategies and Streamlining Through FP-CADD.基于机器学习的药物发现虚拟筛选方法的研究进展:现有策略及 FP-CADD 简化方法
Curr Drug Discov Technol. 2021;18(4):463-472. doi: 10.2174/1570163817666200806165934.
5
An Overview of Computer-aided Drug Design Tools and Recent Applications in Designing of Anti-diabetic Agents.计算机辅助药物设计工具概述及其在抗糖尿病药物设计中的最新应用。
Curr Drug Targets. 2021;22(10):1158-1182. doi: 10.2174/1389450121666201119141525.
6
Cancer Biology Aspects of Computational Methods & Applications in Drug Discovery.计算方法在药物发现中的癌症生物学应用。
Curr Pharm Des. 2018;24(32):3758-3766. doi: 10.2174/1381612824666181112104921.
7
Recent Trends in Computer-aided Drug Design for Anti-cancer Drug Discovery.用于抗癌药物发现的计算机辅助药物设计的最新趋势
Curr Top Med Chem. 2023;23(30):2844-2862. doi: 10.2174/0115680266258467231107102643.
8
Recent Updates on Computer-aided Drug Discovery: Time for a Paradigm Shift.计算机辅助药物发现的最新进展:是时候进行范式转变了。
Curr Top Med Chem. 2017;17(30):3296-3307. doi: 10.2174/1568026618666180101163651.
9
Application of Methods in the Design of Drugs for Neurodegenerative Diseases.方法在神经退行性疾病药物设计中的应用。
Curr Top Med Chem. 2021;21(11):995-1011. doi: 10.2174/1568026621666210521164545.
10
Critical Role of Computer Simulations in Drug Discovery and Development.计算机模拟在药物发现与开发中的关键作用。
Curr Top Med Chem. 2017;17(21):2422-2432. doi: 10.2174/1568026617666170403113541.

引用本文的文献

1
The Art of Finding the Right Drug Target: Emerging Methods and Strategies.寻找正确药物靶点的艺术:新兴方法和策略。
Pharmacol Rev. 2024 Aug 15;76(5):896-914. doi: 10.1124/pharmrev.123.001028.
2
Potential inhibitors of VEGFR1, VEGFR2, and VEGFR3 developed through Deep Learning for the treatment of Cervical Cancer.通过深度学习开发的用于治疗宫颈癌的 VEGFR1、VEGFR2 和 VEGFR3 的潜在抑制剂。
Sci Rep. 2024 Jun 10;14(1):13251. doi: 10.1038/s41598-024-63762-w.
3
In Silico and In Vitro Identification of P-Glycoprotein Inhibitors from a Library of 375 Phytochemicals.
从 375 种植物化学物质库中进行计算和体外鉴定 P-糖蛋白抑制剂。
Int J Mol Sci. 2023 Jun 16;24(12):10240. doi: 10.3390/ijms241210240.
4
Structure-Based Virtual Screening, Molecular Docking, Molecular Dynamics Simulation of EGFR for the Clinical Treatment of Glioblastoma.基于结构的虚拟筛选、EGFR 的分子对接、分子动力学模拟在胶质母细胞瘤临床治疗中的应用。
Appl Biochem Biotechnol. 2023 Aug;195(8):5094-5119. doi: 10.1007/s12010-023-04430-z. Epub 2023 Mar 28.
5
Pharmacological investigation of brucine anti-ulcer potential.马钱子碱抗溃疡潜力的药理学研究。
Front Pharmacol. 2022 Aug 17;13:886433. doi: 10.3389/fphar.2022.886433. eCollection 2022.
6
Recent progress on vascular endothelial growth factor receptor inhibitors with dual targeting capabilities for tumor therapy.近年来血管内皮生长因子受体抑制剂在肿瘤治疗中双重靶向能力的研究进展。
J Hematol Oncol. 2022 Jul 7;15(1):89. doi: 10.1186/s13045-022-01310-7.